Noroxin and Bactrim drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Noroxin (norfloxacin) and Bactrim (sulfamethoxazole; trimethoprim). Common drug interactions include fatigue among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Noroxin and Bactrim. It is created by eHealthMe based on reports of 50 people who take the same drugs from the FDA, and is updated regularly.

What is Noroxin?

Noroxin has active ingredients of norfloxacin. It is often used in urinary tract infection. eHealthMe is studying from 1,675 Noroxin users. Check the latest studies of Noroxin.

What is Bactrim?

Bactrim has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 89,117 Bactrim users. Check the latest studies of Bactrim.



On Aug, 07, 2026

50 people who take Noroxin and Bactrim together, and have interactions are studied.

Noroxin and Bactrim drug interactions.

What are the common drug interactions of Noroxin and Bactrim, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Fracture
  3. Gamma-glutamyltransferase increased
  4. Hepatocellular damage (liver damage)
  5. Hypokalaemia (low potassium)
  6. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  7. Immune system disorder
  8. Insomnia (sleeplessness)
  9. Leukopenia (less number of white blood cells in blood)
  10. Malaise (a feeling of general discomfort or uneasiness)

male:

  1. Abdominal pain
  2. Abnormal behaviour
  3. Lethargy (tiredness)
  4. Nervousness
  5. Prostate cancer
  6. Pyrexia (fever)
  7. Antibiotic associated colitis
  8. Blood creatinine increased
  9. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  10. Cheilitis (infection of lips)

What are the common drug interactions of Noroxin and Bactrim, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Cheilitis (infection of lips)
  2. Conjunctivitis (pink eye)
  3. Erythema multiforme (a type of hypersensitivity reaction)
  4. Pyrexia (fever)

30-39:

  1. Blood creatinine increased
  2. Leukopenia (less number of white blood cells in blood)
  3. Lymphadenopathy (disease or enlargement of lymph nodes)

40-49:

  1. Blood creatinine increased
  2. Drug hypersensitivity

50-59:

  1. Aspartate aminotransferase increased
  2. Hepatocellular damage (liver damage)
  3. Leukopenia (less number of white blood cells in blood)
  4. Nausea (feeling of having an urge to vomit)
  5. Pancreatitis (inflammation of pancreas)
  6. Tachypnoea (a condition of rapid breathing over 20 per minute)
  7. Thrombocytopenic purpura (a bleeding disorder in which the immune system destroys platelets)
  8. Lactic acidosis (low ph in body tissues)
  9. Pancreatitis acute (sudden inflammation of pancreas)
  10. Hepatitis (inflammation of the liver)

60+:

  1. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  2. Odynophagia (painful swallowing, in the mouth (oropharynx) or oesophagus)
  3. Libido increased (increased sexual urge to have sex)
  4. Pruritus (severe itching of the skin)
  5. Pyrexia (fever)
  6. Thrombocythaemia (an increased number of platelets in the circulating blood)
  7. Chronic kidney disease
  8. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  9. Renal failure (kidney dysfunction)
  10. Acute generalised exanthematous pustulosis (acute febrile drug eruption)

What are the existing conditions these people have? *

  1. Gastritis (inflammation of stomach): 6 people, 12.00%
  2. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 5 people, 10.00%
  3. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 5 people, 10.00%
  4. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 5 people, 10.00%
  5. Type 2 Diabetes: 4 people, 8.00%
  6. Pain: 4 people, 8.00%
  7. Chronic Thyroiditis (long lasting inflammation of thyroid gland): 4 people, 8.00%
  8. Multiple Myeloma (cancer of the plasma cells): 3 people, 6.00%
  9. Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract): 3 people, 6.00%
  10. High Blood Pressure: 3 people, 6.00%

* Approximation only. Some reports may have incomplete information.

Do you take Noroxin and Bactrim?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Noroxin and Bactrim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Noroxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bactrim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Noroxin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bactrim and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on norfloxacin and sulfamethoxazole; trimethoprim (the active ingredients of Noroxin and Bactrim, respectively), and Noroxin and Bactrim (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: